陈茂波:香港可在世界湾区合作中作出独特贡献

中国成功发射实践二十四号卫星

投资未来·共赢全球|2026投资未来机会大会 企业出海“走出去”专题论坛在沪举办

中外摄影师行摄广元苍溪聚焦水上大蜀道

谁在海上拯救你?从里斯本丸号救援到今天的舟山

中国匹克球积分体系落地香港 CPC-600 赛事助推大湾区体育联动

China's phase 2 trial finds COVID-19 vaccine safe, inducing immune response -- The Lancet

发布时间:   来源: 粤港澳头条
File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)

File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)

 

A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.

上一篇:Xi inspects PLA aviation university ahead of Army Day
下一篇:China slams U.S. over curb on tech visas

首页   |   

Copyright © http://www.yhkmac.com 粤港澳头条 版权所有